Haemophilia, ISSN 1351-8216, 09/2018, Volume 24, Issue 5, pp. 726 - 732
Background In older people, multiple chronic ailments lead to the intake of multiple medications (polypharmacy) that carry a number of negative consequences...
haemophilia | drug appropriateness | comorbidity | drug interactions | deprescribing | polypharmacy | MORTALITY | DEATH | PEOPLE | HEMATOLOGY | Polypharmacy | Prevalence | Age Factors | Humans | Risk Factors | Female | Male | Hemophilia A - drug therapy | Hemophilia A - pathology | Drugs | Prescribing | Antiviral agents | Comorbidity | Liver | Mortality | Hemophilia | Aged patients | Family medicine | Plants | Comparative analysis | Aging | Liver diseases
haemophilia | drug appropriateness | comorbidity | drug interactions | deprescribing | polypharmacy | MORTALITY | DEATH | PEOPLE | HEMATOLOGY | Polypharmacy | Prevalence | Age Factors | Humans | Risk Factors | Female | Male | Hemophilia A - drug therapy | Hemophilia A - pathology | Drugs | Prescribing | Antiviral agents | Comorbidity | Liver | Mortality | Hemophilia | Aged patients | Family medicine | Plants | Comparative analysis | Aging | Liver diseases
Journal Article
Thrombosis Research, ISSN 0049-3848, 01/2020, Volume 185, pp. 85 - 87
Journal Article
Hematology Reports, ISSN 2038-8322, 02/2019, Volume 11, Issue 1, pp. 4 - 5
Despite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical...
Recombinant FXIII | Surgery | Congenital FXIII deficiency | congenital FXIII deficiency | surgery
Recombinant FXIII | Surgery | Congenital FXIII deficiency | congenital FXIII deficiency | surgery
Journal Article
JOURNAL OF CLINICAL MEDICINE, ISSN 2077-0383, 09/2017, Volume 6, Issue 9, p. 85
Von Willebrand disease (VWD) is the most frequent inherited bleeding disorder and is caused by either a quantitative and/or qualitative defect of the...
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | PATIENT | MANAGEMENT | FACTOR VIIA NOVOSEVEN(R) | n/a
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | PATIENT | MANAGEMENT | FACTOR VIIA NOVOSEVEN(R) | n/a
Journal Article
Italian Journal of Pediatrics, ISSN 1720-8424, 2015, Volume 41, Issue 1, p. 12
Hemophilia B is a rare X-linked recessive disorder with plasma factor IX (FIX) deficiency. 1-3% of patients treated with exogenous FIX-containing products...
Factor IX deficiency | Desensitization | Inhibitor antibodies | Children | Immune tolerance induction | HEMOPHILIA-B PATIENTS | MANAGEMENT | RISK | PEDIATRICS | MECHANISMS | VIII | ANAPHYLAXIS | Factor IX - administration & dosage | Hemophilia B - immunology | Factor IX - immunology | Humans | Immunologic Factors - administration & dosage | Immunologic Factors - immunology | Child, Preschool | Male | Factor IX - adverse effects | Recombinant Proteins - administration & dosage | Hemophilia B - drug therapy | Immune Tolerance - immunology | Immunologic Factors - adverse effects | Desensitization, Immunologic
Factor IX deficiency | Desensitization | Inhibitor antibodies | Children | Immune tolerance induction | HEMOPHILIA-B PATIENTS | MANAGEMENT | RISK | PEDIATRICS | MECHANISMS | VIII | ANAPHYLAXIS | Factor IX - administration & dosage | Hemophilia B - immunology | Factor IX - immunology | Humans | Immunologic Factors - administration & dosage | Immunologic Factors - immunology | Child, Preschool | Male | Factor IX - adverse effects | Recombinant Proteins - administration & dosage | Hemophilia B - drug therapy | Immune Tolerance - immunology | Immunologic Factors - adverse effects | Desensitization, Immunologic
Journal Article
Open Journal of Blood Diseases, ISSN 2164-3180, 2013, Volume 3, Issue 1, pp. 13 - 14
Journal Article
Haemophilia, ISSN 1351-8216, 09/2018, Volume 24, Issue 5, pp. 766 - 773
Introduction Persons with haemophilia (PWH) experience recurrent joint bleeding which leads from early synovitis to irreversible joint damage. Pain strongly...
haemophilia | survey | pain | analgesic | comprehensive care | patient | BLEEDING DISORDERS | ARTHROPATHY | ADULTS | CHILDREN | PROPHYLAXIS | THERAPY | ADOLESCENTS | QUALITY-OF-LIFE | HEMATOLOGY | SEVERITY | Physicians | Humans | Middle Aged | Pain Management - methods | Male | Hemophilia A - pathology | Hemophilia A - complications | Young Adult | Pain Measurement - methods | Adolescent | Adult | Female | Italy | Surveys and Questionnaires | Aged | Child | Chronic Pain - etiology | Surveys | COX-2 inhibitors | Care and treatment | Pain | Fluocinolone acetonide | Opioids | Hemophilia | Chronic pain | Synovitis | Prophylaxis | Inflammation | Management | Patients | Quality of life | Oxygenase | Paracetamol | Children
haemophilia | survey | pain | analgesic | comprehensive care | patient | BLEEDING DISORDERS | ARTHROPATHY | ADULTS | CHILDREN | PROPHYLAXIS | THERAPY | ADOLESCENTS | QUALITY-OF-LIFE | HEMATOLOGY | SEVERITY | Physicians | Humans | Middle Aged | Pain Management - methods | Male | Hemophilia A - pathology | Hemophilia A - complications | Young Adult | Pain Measurement - methods | Adolescent | Adult | Female | Italy | Surveys and Questionnaires | Aged | Child | Chronic Pain - etiology | Surveys | COX-2 inhibitors | Care and treatment | Pain | Fluocinolone acetonide | Opioids | Hemophilia | Chronic pain | Synovitis | Prophylaxis | Inflammation | Management | Patients | Quality of life | Oxygenase | Paracetamol | Children
Journal Article
Haemophilia, ISSN 1351-8216, 07/2019, Volume 25, Issue 4, pp. 656 - 667
Vaccination against communicable diseases is crucial for disease prevention, but this practice poses challenges to healthcare professionals in patients with...
haemophilia | factor VIII inhibitor | immunization | bleeding disorder | vaccination | BLEEDING DISORDERS | FACTOR-VIII | GUIDELINES | CHILDREN | HEPATITIS-B VACCINATION | INHIBITOR DEVELOPMENT | UPDATE | HEMATOLOGY | VACCINES | Care and treatment | Blood coagulation factor VIII | Communicable diseases | Vaccination | Hemophilia
haemophilia | factor VIII inhibitor | immunization | bleeding disorder | vaccination | BLEEDING DISORDERS | FACTOR-VIII | GUIDELINES | CHILDREN | HEPATITIS-B VACCINATION | INHIBITOR DEVELOPMENT | UPDATE | HEMATOLOGY | VACCINES | Care and treatment | Blood coagulation factor VIII | Communicable diseases | Vaccination | Hemophilia
Journal Article
Blood, ISSN 0006-4971, 07/2012, Volume 120, Issue 1, pp. 47 - 55
Journal Article
International Journal of General Medicine, ISSN 1178-7074, 2010, Volume 3, pp. 203 - 208
Needlestick injuries, mostly due to unsafe needle devices, are a frequent adverse event among health care workers and patients on chronic treatment, such as...
Therapy | Kogenate® bayer | Safety | Bio-set | Hemophilia | Patients | Needlestick injuries | hemophilia | Kogenate® Bayer | therapy | safety | Bio-Set
Therapy | Kogenate® bayer | Safety | Bio-set | Hemophilia | Patients | Needlestick injuries | hemophilia | Kogenate® Bayer | therapy | safety | Bio-Set
Journal Article
11.
Full Text
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management
Blood Transfusion, ISSN 1723-2007, 07/2015, Volume 13, Issue 3, pp. 498 - 513
SYSTEMIC-LUPUS-ERYTHEMATOSUS | SINGLE-CENTER EXPERIENCE | IMMUNOSUPPRESSIVE THERAPY | FACTOR-VIII INHIBITORS | HEMOPHILIA REGISTRY EACH2 | FACTOR-X DEFICIENCY | FACTOR-IX | PORCINE FACTOR-VIII | INTERNATIONAL REGISTRY | HEMATOLOGY | VON-WILLEBRAND-SYNDROME | Autoantibodies - blood | Humans | Female | Male | Hemophilia A - diagnosis | Hemophilia A - therapy | Hemophilia A - blood | Blood Coagulation Factor Inhibitors - blood | Recommendation
Journal Article
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 01/2006, Volume 12, Issue 1, pp. 115 - 116
The case of a 41-year-old woman with Glanzmann’s thrombasthenia who underwent double dental extraction is presented. In the past, treatments with desmopressin...
Journal Article
13.
Full Text
Hyperhomocysteinemia and C677T MTHFR Genotype in Patients With Retinal Vein Thrombosis
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 10/2010, Volume 16, Issue 5, pp. 549 - 553
Introduction: Elevated homocysteine (Hcy) is associated with the risk of deep vein thrombosis, pulmonary embolism, ischemic heart disease, and stroke. Several...
Thrombophilia | Gene polymorphisms | Venous thromboembolism | thrombophilia | POPULATION | RISK-FACTOR | venous thromboembolism | MUTATION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | PLASMA HOMOCYSTEINE | gene polymorphisms | VASCULAR-DISEASE | OCCLUSION | Genetic Predisposition to Disease | Hyperhomocysteinemia - blood | Humans | Middle Aged | Risk Factors | Genotype | Male | Retinal Vein Occlusion - blood | Retinal Vein Occlusion - genetics | Case-Control Studies | Polymorphism, Genetic | Young Adult | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Aged, 80 and over | Adult | Female | Hyperhomocysteinemia - genetics | Aged | Retrospective Studies | Cohort Studies
Thrombophilia | Gene polymorphisms | Venous thromboembolism | thrombophilia | POPULATION | RISK-FACTOR | venous thromboembolism | MUTATION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | PLASMA HOMOCYSTEINE | gene polymorphisms | VASCULAR-DISEASE | OCCLUSION | Genetic Predisposition to Disease | Hyperhomocysteinemia - blood | Humans | Middle Aged | Risk Factors | Genotype | Male | Retinal Vein Occlusion - blood | Retinal Vein Occlusion - genetics | Case-Control Studies | Polymorphism, Genetic | Young Adult | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Aged, 80 and over | Adult | Female | Hyperhomocysteinemia - genetics | Aged | Retrospective Studies | Cohort Studies
Journal Article
14.
Full Text
High Incidence of Factor V Leiden and Prothrombin G20210A in Healthy Southern Italians
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 06/2009, Volume 15, Issue 3, pp. 356 - 359
Factor V Leiden (FVL) and G20210 prothrombin (FII G20210A) mutations are risk factors for thromboembolism. In Europe, FVL is more prevalent in the north (7%)...
Thrombophilia | Factor V Leiden | Prothrombin G20210 | thrombophilia | factor V Leiden | POPULATION | ORIGIN | VENOUS THROMBOEMBOLISM | GENE | prothrombin G20210 | PERIPHERAL VASCULAR DISEASE | PREVALENCE | MUTATIONS | 3-UNTRANSLATED REGION | HEMATOLOGY | European Continental Ancestry Group - genetics | Gene Frequency | Humans | Male | Reference Values | Polymorphism, Genetic | Homozygote | Adult | Female | Heterozygote | Italy | Prothrombin - genetics | Factor V - genetics
Thrombophilia | Factor V Leiden | Prothrombin G20210 | thrombophilia | factor V Leiden | POPULATION | ORIGIN | VENOUS THROMBOEMBOLISM | GENE | prothrombin G20210 | PERIPHERAL VASCULAR DISEASE | PREVALENCE | MUTATIONS | 3-UNTRANSLATED REGION | HEMATOLOGY | European Continental Ancestry Group - genetics | Gene Frequency | Humans | Male | Reference Values | Polymorphism, Genetic | Homozygote | Adult | Female | Heterozygote | Italy | Prothrombin - genetics | Factor V - genetics
Journal Article
American Journal of Clinical Hypnosis, ISSN 0002-9157, 04/2011, Volume 53, Issue 4, pp. 203 - 208
Journal Article
Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, 2007, Volume 86, Issue 2, pp. 247 - 248
Pregnancy | Thrombophilia | Hypodysfibrinogenemia | Hemorrhage | Abruptio placentae | thrombophilia | DYSFIBRINOGENEMIA | hypodysfibrinogenemia | FETAL LOSS | pregnancy | AFIBRINOGENEMIA | abruptio placentae | hemorrhage | OBSTETRICS & GYNECOLOGY | Abruptio Placentae | Humans | Stillbirth | Anticoagulants - therapeutic use | Heparin - therapeutic use | Enoxaparin - therapeutic use | Warfarin - therapeutic use | Puerperal Disorders - drug therapy | Puerperal Disorders - etiology | Intracranial Thrombosis - etiology | Fibrinogens, Abnormal - adverse effects | Adult | Female | Intracranial Thrombosis - drug therapy
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 01/2011, Volume 9, Issue 1, pp. 140 - 148
Background: The WHO scheme for prothrombin time (PT) standardization has been limited in application, because of its difficulties in implementation,...
INR correction | prothrombin time | coagulometers | ECAA plasmas | thromboplastins | INR Line | PT/INR Line | Coagulometers | Prothrombin time | Thromboplastins | MULTICENTER | PLASMA CALIBRANTS | FIELD | ENHANCED STANDARDIZATION | INTERNATIONAL SENSITIVITY INDEX | QUALITY ASSESSMENT | PERIPHERAL VASCULAR DISEASE | TIME MONITORS | HEMATOLOGY | ISI | Prothrombin Time - standards | Predictive Value of Tests | Rabbits | Reproducibility of Results | World Health Organization | Humans | Automation, Laboratory - standards | Linear Models | Thromboplastin - analysis | Calibration | International Normalized Ratio - standards | Reference Standards | Animals | Analysis of Variance | Cattle | Blood Coagulation | Observer Variation | Medical examination | Chemical tests and reagents | Prothrombin | Thrombin | Anticoagulants (Medicine) | Universities and colleges | Blood
INR correction | prothrombin time | coagulometers | ECAA plasmas | thromboplastins | INR Line | PT/INR Line | Coagulometers | Prothrombin time | Thromboplastins | MULTICENTER | PLASMA CALIBRANTS | FIELD | ENHANCED STANDARDIZATION | INTERNATIONAL SENSITIVITY INDEX | QUALITY ASSESSMENT | PERIPHERAL VASCULAR DISEASE | TIME MONITORS | HEMATOLOGY | ISI | Prothrombin Time - standards | Predictive Value of Tests | Rabbits | Reproducibility of Results | World Health Organization | Humans | Automation, Laboratory - standards | Linear Models | Thromboplastin - analysis | Calibration | International Normalized Ratio - standards | Reference Standards | Animals | Analysis of Variance | Cattle | Blood Coagulation | Observer Variation | Medical examination | Chemical tests and reagents | Prothrombin | Thrombin | Anticoagulants (Medicine) | Universities and colleges | Blood
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2004, Volume 126, Issue 2, p. 163
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2004, Volume 126, Issue 2, pp. 163 - 163
HIV Infections - diagnostic imaging | Psoas Muscles - pathology | Hemophilia A - diagnostic imaging | Humans | Hematoma - diagnostic imaging | Hematoma - diagnosis | Hematoma - etiology | Male | Tomography, X-Ray Computed | Psoas Muscles - diagnostic imaging | Hemophilia A - pathology | Hemophilia A - complications | Muscular Diseases - etiology | Muscular Diseases - diagnosis | Magnetic Resonance Imaging | Ilium - diagnostic imaging | HIV Infections - pathology | HIV Infections - complications | Ilium - pathology | Adult | Hepatitis C - complications | Hepatitis C - diagnostic imaging | Hepatitis C - pathology | Muscular Diseases - diagnostic imaging
Journal Article
Clinical and Applied Thrombosis/Hemostasis, ISSN 1076-0296, 01/2006, Volume 12, Issue 1, pp. 115 - 116
The case of a 41-year-old woman with Glanzmann's thrombasthenia who underwent double dental extraction is presented. In the past, treatments with desmopressin...
Glanzmann's thrombasthenia | Dental extraction | Recombinant activated factor VII | dental extraction | DDAVP | DISORDERS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | recombinant activated factor VII | Recombinant Proteins - therapeutic use | Blood Loss, Surgical - prevention & control | Tooth Extraction - methods | Factor VII - therapeutic use | Humans | Adult | Female | Thrombasthenia - complications | Drug Therapy, Combination | Deamino Arginine Vasopressin - therapeutic use | Factor VIIa
Glanzmann's thrombasthenia | Dental extraction | Recombinant activated factor VII | dental extraction | DDAVP | DISORDERS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | recombinant activated factor VII | Recombinant Proteins - therapeutic use | Blood Loss, Surgical - prevention & control | Tooth Extraction - methods | Factor VII - therapeutic use | Humans | Adult | Female | Thrombasthenia - complications | Drug Therapy, Combination | Deamino Arginine Vasopressin - therapeutic use | Factor VIIa
Journal Article